Atlas Trials

Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy

Clinical trial NCT07260526 · RECRUITING

Trial details

NCT number
NCT07260526
Sponsor
West China Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Rectal Cancer
Start date
2025-10-01
Primary completion
2026-10-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.